New antibiotics capable of killing drug-resistant gonorrhoea have been developed by AI. Experts believe that Artificial Intelligence could signify a'second golden age' of antibiotic discovery, after creating two drugs that could be capable of killing superbugs such as gonorrhea and MRSA. Led by Professor James Collins at the Massachusetts Institute of Technology (MIT), a specialist research team used generative AI algorithms to interrogate 36million compounds. The experts then trained the AI to help it learn how bacteria was affected by different molecular structures built of atoms in order to design new antibiotics. In order to do this, they gave it the chemical structure of known compounds and data on their ability to hinder the growth of different bacteria species. Throughout the study, published in the journal Cell, anything too similar to the current antibiotics available, or with the potential to be toxic to human beings, was eradicated.

Doctors believe Artificial Intelligence is now saving lives, after a major advancement in breast cancer screenings. A.I. is detecting early signs of the disease, in some cases years before doctors would find the cancer on a traditional scan. Scientists have found a drug that could combat drug-resistant infections – and they did it using artificial intelligence. Using a machine-learning algorithm, researchers at the Massachusetts Institute of Technology (MIT) and Canada's McMaster University have identified a new antibiotic that can kill a type of bacteria responsible for many drug-resistant infections. The compound kills Acinetobacter baumannii, which is a species of bacteria often found in hospitals.

In late February, a paper appeared in the journal Cell with encouraging news regarding one of the world's most persistent public health problems. Researchers at Massachusetts Institute of Technology and Harvard University had used artificial intelligence to identify a chemical compound with powerful antibiotic properties against some of the world's most drug-resistant strains of bacteria -- a welcome discovery in a world where 700,000 people die every year from drug-resistant infections. It was the first time an antibacterial compound had been identified this way. The researchers named it halicin, in honor of the computer HAL in the film 2001: Space Odyssey. While the global need for new antibiotics to treat drug-resistant infections is as pressing as it was at the start of the year, the world's attention has been diverted by the novel coronavirus pandemic, and the hunt for a vaccine that can halt Covid's spread.